CAS 76956-02-0

Loxtidine

Description:

Loxtidine is a chemical compound classified as a histamine H2 receptor antagonist, primarily used in the treatment of conditions such as peptic ulcers and gastroesophageal reflux disease (GERD). It works by inhibiting the action of histamine at the H2 receptors in the stomach lining, thereby reducing gastric acid secretion. Loxtidine is characterized by its ability to promote healing of the gastric mucosa and alleviate symptoms associated with excessive stomach acid. The compound has a specific molecular structure that contributes to its pharmacological activity, and it is typically administered orally. As with other H2 antagonists, potential side effects may include headache, dizziness, and gastrointestinal disturbances. It is important to note that while Loxtidine was studied for its therapeutic effects, its clinical use may vary by region and over time, and it may not be as widely used as other H2 blockers. Always consult healthcare professionals for the most current information regarding medications and their applications.

Formula: C₁₉H₂₉N₅O₂

InChI: InChI=1S/C19H29N5O2/c1-23-19(21-18(15-25)22-23)20-9-6-12-26-17-8-5-7-16(13-17)14-24-10-3-2-4-11-24/h5,7-8,13,25H,2-4,6,9-12,14-15H2,1H3,(H,20,21,22)

InChI key: InChIKey=VTLNPNNUIJHJQB-UHFFFAOYSA-N

SMILES: C(C1=CC(OCCCNC2=NC(CO)=NN2C)=CC=C1)N3CCCCC3

Synonyms:

• 1-Methyl-5-[[3-[3-(1-piperidinylmethyl)phenoxy]propyl]amino]-1H-1,2,4-triazole-3-methanol
• 1H-1,2,4-Triazole-3-methanol, 1-methyl-5-[[3-[3-(1-piperidinylmethyl)phenoxy]propyl]amino]-
• Ah 23844
• Ahr 23844
• Loxotidine
• Loxtidine
• [1-methyl-5-({3-[3-(piperidin-1-ylmethyl)phenoxy]propyl}amino)-1H-1,2,4-triazol-3-yl]methanol
• Lavoltidine

Lavoltidine

CAS: 76956-02-0

Lavoltidine (Loxtidine) is potent and selective H2 receptor antagonist, oral and irreversible,inhibits gastric acid secretion, gastroesophageal reflux disease.

Formula: C₁₉H₂₉N₅O₂

Purity: 98.30% - 98.36%

Color and Shape: Solid

Molecular weight: 359.47

Ref: TM-T15722